Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?
- PMID: 26868907
- PMCID: PMC4946886
- DOI: 10.1038/cdd.2015.168
Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?
Abstract
Mesenchymal stem cells (MSCs), a non-hematopoietic stem cell population first discovered in bone marrow, are multipotent cells capable of differentiating into mature cells of several mesenchymal tissues, such as fat and bone. As common progenitor cells of adipocytes and osteoblasts, MSCs are delicately balanced for their differentiation commitment. Numerous in vitro investigations have demonstrated that fat-induction factors inhibit osteogenesis, and, conversely, bone-induction factors hinder adipogenesis. In fact, a variety of external cues contribute to the delicate balance of adipo-osteogenic differentiation of MSCs, including chemical, physical, and biological factors. These factors trigger different signaling pathways and activate various transcription factors that guide MSCs to commit to either lineage. The dysregulation of the adipo-osteogenic balance has been linked to several pathophysiologic processes, such as aging, obesity, osteopenia, osteopetrosis, and osteoporosis. Thus, the regulation of MSC differentiation has increasingly attracted great attention in recent years. Here, we review external factors and their signaling processes dictating the reciprocal regulation between adipocytes and osteoblasts during MSC differentiation and the ultimate control of the adipo-osteogenic balance.
Figures




Similar articles
-
Marrow adipocytes inhibit the differentiation of mesenchymal stem cells into osteoblasts via suppressing BMP-signaling.J Biomed Sci. 2017 Feb 7;24(1):11. doi: 10.1186/s12929-017-0321-4. J Biomed Sci. 2017. PMID: 28173811 Free PMC article.
-
Dexamethasone in osteogenic medium strongly induces adipocyte differentiation of mouse bone marrow stromal cells and increases osteoblast differentiation.BMC Cell Biol. 2015 Mar 13;16:9. doi: 10.1186/s12860-015-0056-6. BMC Cell Biol. 2015. PMID: 25887471 Free PMC article.
-
Enhancer of Zeste Homolog 2 and Histone Deacetylase 9c Regulate Age-Dependent Mesenchymal Stem Cell Differentiation into Osteoblasts and Adipocytes.Stem Cells. 2016 Aug;34(8):2183-93. doi: 10.1002/stem.2400. Epub 2016 Jun 20. Stem Cells. 2016. PMID: 27250566
-
The role of microRNAs in cell fate determination of mesenchymal stem cells: balancing adipogenesis and osteogenesis.BMB Rep. 2015 Jun;48(6):319-23. doi: 10.5483/bmbrep.2015.48.6.206. BMB Rep. 2015. PMID: 25341923 Free PMC article. Review.
-
Thy-1: more than a marker for mesenchymal stromal cells.FASEB J. 2019 Jun;33(6):6689-6696. doi: 10.1096/fj.201802224R. Epub 2019 Feb 27. FASEB J. 2019. PMID: 30811954 Review.
Cited by
-
Circular RNA SIPA1L1 promotes osteogenesis via regulating the miR-617/Smad3 axis in dental pulp stem cells.Stem Cell Res Ther. 2020 Aug 24;11(1):364. doi: 10.1186/s13287-020-01877-3. Stem Cell Res Ther. 2020. PMID: 32831141 Free PMC article.
-
Analysis of RAMP3 gene polymorphism with body composition and bone density in young and elderly women.Gene X. 2019 Feb 14;2:100009. doi: 10.1016/j.gene.2019.100009. eCollection 2019 Jun. Gene X. 2019. PMID: 32550545 Free PMC article.
-
CD49f and CD146: A Possible Crosstalk Modulates Adipogenic Differentiation Potential of Mesenchymal Stem Cells.Cells. 2023 Dec 27;13(1):55. doi: 10.3390/cells13010055. Cells. 2023. PMID: 38201259 Free PMC article.
-
SLAMF8 regulates osteogenesis and adipogenesis of bone marrow mesenchymal stem cells via S100A6/Wnt/β-catenin signaling pathway.Stem Cell Res Ther. 2024 Oct 8;15(1):349. doi: 10.1186/s13287-024-03964-1. Stem Cell Res Ther. 2024. PMID: 39380096 Free PMC article.
-
Assessment and Comparison of the Efficacy of Methotrexate, Prednisolone, Adalimumab, and Tocilizumab on Multipotency of Mesenchymal Stem Cells.Front Pharmacol. 2020 Jul 3;11:1004. doi: 10.3389/fphar.2020.01004. eCollection 2020. Front Pharmacol. 2020. PMID: 32719606 Free PMC article.
References
-
- Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289: 1504–1508. - PubMed
-
- Caplan AI. Mesenchymal stem-cells. J Orthop Res 1991; 9: 641–650. - PubMed
-
- Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7: 393–395. - PubMed
-
- Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WWK, Gordon PL, Neel M et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309–313. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials